Concepedia

Amh-based Stimulation

AMH-Based Stimulation is a protocol for ovarian stimulation in assisted reproductive technology that uses anti-Müllerian hormone (AMH) levels as the primary biomarker to individualize gonadotropin dosing, thereby distinguishing it from other stimulation protocols that rely predominantly on age, antral follicle count, or body mass index for treatment customization.

23

Publications

1.1K

Citations

140

Authors

60

Institutions

Publications per year

2017–2026

12

Parents

Publications

23

Basal and stimulation day 5 anti-Müllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist–gonadotropin treatment

Joana Peñarrubia, Francisco Fábregues, Dolors Manau et al. · Human Reproduction · 2005 · 199 citations · Full text

, , +12

Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF

Allen P. Yates, Oybek Rustamov, S. A. Roberts et al. · Human Reproduction · 2011 · 151 citations

, , +15

A quantitative and interspecific test for biological activity of anti-Müllerian hormone: the fetal ovary aromatase assay

Nathalie di Clemente, Sarah Ghaffari, R. Blake Pepinsky et al. · Development · 1992 · 145 citations

, , +17

The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments

Ellen Anckaert, Johan Smitz, Johan Schiettecatte et al. · Human Reproduction · 2012 · 94 citations · Full text

, , +17

Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF/ICSI patients: a randomized controlled trial

Osamu Ishihara, Joan‐Carles Arce · Reproductive BioMedicine Online · 2021 · 70 citations

, , +14

1–5 of 23

Authors

140

  1. AN
    Anders Nyboe Andersen

    Rigshospitalet, Denmark

    2 publications · 56 citations

    2

    h-index

  2. AL
    Antonio La Marca

    University of Modena and Reggio Emilia, Italy

    2 publications · 46 citations

    2

    h-index

  3. JA
    Joan‐Carles Arce

    Ferring Pharmaceuticals (Denmark), Denmark

    2 publications · 164 citations

    2

    h-index

  4. BM
    Bjarke M. Klein

    Ferring Pharmaceuticals (Denmark), Denmark

    2 publications · 118 citations

    2

    h-index

  5. EA
    Ellen Anckaert

    Universitair Ziekenhuis Brussel, Belgium

    2 publications · 105 citations

    2

    h-index

1–5 of 140

Institutions

60

  1. Ferring Pharmaceuticals (Denmark)

    Copenhagen, Denmark

    3 h-index

    5 publications

    306 citations

  2. University of Modena and Reggio Emilia

    Modena, Italy

    2 h-index

    2 publications

    46 citations

  3. Rigshospitalet

    Copenhagen, Denmark

    2 h-index

    9 publications

    265 citations

  4. Shanghai Jiao Tong University

    Shanghai, China

    1 h-index

    10 publications

    300 citations

  5. Biogen (United States)

    Cambridge, United States

    1 h-index

    2 publications

    290 citations

  6. Universitat de Barcelona

    Barcelona, Spain

    1 h-index

    1 publications

    199 citations

  7. Chongqing Public Health Medical Center

    Chongqing, China

    1 h-index

    2 publications

    40 citations

  8. Sir Ganga Ram Hospital

    New Delhi, India

    1 h-index

    4 publications

    160 citations

1–8 of 60

Venues

  1. Human Reproduction

    4 publications · 483 citations

    4

    h-index

  2. Frontiers in Endocrinology

    3 publications · 80 citations

    3

    h-index

  3. Gynecological Endocrinology

    2 publications · 46 citations

    2

    h-index

  4. 2

    h-index

  5. Journal of Human Reproductive Sciences

    JHRS · 2 publications · 68 citations

    2

    h-index

1–5